Australian Clinical Labs Ltd (AU:ACL) has released an update.
Mitsubishi UFJ Financial Group, Inc. has emerged as a substantial holder in Australian Clinical Labs Ltd, with a total voting power of 5.01% across 10,109,010 fully paid ordinary shares. The significant acquisition by Mitsubishi UFJ Financial Group was formalized on April 17, 2024, and reflects their strategic interest in the healthcare diagnostics company. The shares are held through a variety of entities, with Mitsubishi having over 20% voting power in Morgan Stanley and full control over First Sentier Investors Holdings Pty Limited.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
